These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9413494)

  • 1. From efficacy to cost-effectiveness.
    Kernick DP
    Lancet; 1997 Dec; 350(9093):1781. PubMed ID: 9413494
    [No Abstract]   [Full Text] [Related]  

  • 2. From efficacy to cost-effectiveness.
    Thompson S; Barber J
    Lancet; 1997 Dec; 350(9093):1781-2. PubMed ID: 9413495
    [No Abstract]   [Full Text] [Related]  

  • 3. On cost effectiveness and sample size in clinical trials.
    Hart AA; Dijkgraaf MG
    Pharmacoeconomics; 2004; 22(10):685-8, author reply 688-9. PubMed ID: 15244493
    [No Abstract]   [Full Text] [Related]  

  • 4. A framework for cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW
    Health Econ; 2001 Jun; 10(4):303-15. PubMed ID: 11400253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW; Montmartin J
    Stat Med; 2001 Mar; 20(5):733-53. PubMed ID: 11241573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial.
    Wilkinson HA
    Neurosurgery; 2008 Aug; 63(2):E376; author reply E376. PubMed ID: 18797322
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic analysis and complex randomized controlled trials.
    Delaney B
    Fam Pract; 2007 Sep; 24(4):293-4. PubMed ID: 17728291
    [No Abstract]   [Full Text] [Related]  

  • 8. How should cost data in pragmatic randomised trials be analysed?
    Thompson SG; Barber JA
    BMJ; 2000 Apr; 320(7243):1197-200. PubMed ID: 10784550
    [No Abstract]   [Full Text] [Related]  

  • 9. Are systematic reviews more cost-effective than randomised trials?
    Glasziou P; Djulbegovic B; Burls A
    Lancet; 2006 Jun; 367(9528):2057-8. PubMed ID: 16798380
    [No Abstract]   [Full Text] [Related]  

  • 10. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data.
    Willan AR; Briggs AH; Hoch JS
    Health Econ; 2004 May; 13(5):461-75. PubMed ID: 15127426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding cost to NNT: the COPE statistic.
    Maharaj R
    ACP J Club; 2008; 148(1):A8. PubMed ID: 18170986
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomization within quality registries: a cost-effective complement to classical randomized trials.
    Eur Heart J; 2014 Jan; 35(1):1-2. PubMed ID: 24382633
    [No Abstract]   [Full Text] [Related]  

  • 13. Adding cost to number needed to treat: the COPE statistic.
    Maharaj R
    Evid Based Med; 2007 Aug; 12(4):101-2. PubMed ID: 17885150
    [No Abstract]   [Full Text] [Related]  

  • 14. Correction.
    Evid Based Med; 2015 Aug; 20(4):123. PubMed ID: 26209721
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic evaluation and clinical trials: size matters.
    Briggs A
    BMJ; 2000 Dec; 321(7273):1362-3. PubMed ID: 11099268
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacoeconomics: integrating economic evaluation into clinical trials.
    Haycox A; Drummond M; Walley T
    Br J Clin Pharmacol; 1997 Jun; 43(6):559-62. PubMed ID: 9205814
    [No Abstract]   [Full Text] [Related]  

  • 17. Implementing randomization procedures in the Asthma Clinical Research Network.
    McEntegart D
    Control Clin Trials; 2002 Aug; 23(4):424-6; author reply 426-8. PubMed ID: 12161085
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of different study designs: an overlooked parameter in clinical research.
    Falagas ME; Bliziotis IA
    J Clin Epidemiol; 2007 Mar; 60(3):215-6. PubMed ID: 17292014
    [No Abstract]   [Full Text] [Related]  

  • 19. Incremental net benefit in randomized clinical trials.
    Willan AR; Lin DY
    Stat Med; 2001 Jun; 20(11):1563-74. PubMed ID: 11391688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness and clinical efficacy of patent foramen ovale closure as compared to medical therapy in cryptogenic stroke patients: A detailed cost analysis and meta-analysis of randomized controlled trials.
    Pickett CA; Villines TC; Resar JR; Hulten EA
    Int J Cardiol; 2018 Dec; 273():74-79. PubMed ID: 30119914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.